Since the discovery of betatrophin has raised new hope for therapeutic approaches or identification of a potential biomarker for metabolic disorders, there is an increasing interest in measurement of the circulating level of betatrophin in humans. This evidence concerns the gene ANGPTL8 and Other metabolic disease.